D.E. Shaw & Co’s Immunomedics Inc IMMU Stock Holding History

D.E. Shaw & Co’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-40,000	Closed	-$3.4M	–	4309
2020 Q3	$3.4M	Buy	40,000 +25,000	+167%	+$1.26M	﹤0.01%	1976
2020 Q2	$532K	Buy	15,000 +5,000	+50%	+$146K	﹤0.01%	3331
2020 Q1	$135K	Buy	+10,000	New	+$168K	﹤0.01%	3738
2017 Q4	–	Sell	-45,000	Closed	-$629K	–	3819
2017 Q3	$629K	Hold	45,000	–	–	﹤0.01%	2786
2017 Q2	$397K	Buy	+45,000	New	+$316K	﹤0.01%	2912

D.E. Shaw & Co's IMMU Position: Q4 2020 in Review

D.E. Shaw & Co sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,514,427 shares — an estimated $129M sold.

D.E. Shaw & Co first reported a position in IMMU in Q1 2014 and held it in 21 quarters. The position peaked at $129M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

D.E. Shaw & Co reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
D.E. Shaw & Co sold 1,514,427 Immunomedics Inc shares in Q4 2020, an estimated $129M.
D.E. Shaw & Co first reported a position in Immunomedics Inc in Q1 2014 and held it in 21 quarters.
D.E. Shaw & Co's Immunomedics Inc position peaked at $129M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on D.E. Shaw & Co's 13F filing for Q4 2020, filed 16 Feb 2021.